LALPATHLAB — Dr. Lal PathLabs Share News
0.000.00%
Last trade - 00:00- IN₹311.00bn
- IN₹299.44bn
- IN₹27.63bn
Brief: Dr. Lal Pathlabs Says NCLT Sanctioned Scheme Of Amalgamation Between Co And APL Institute Of Clinical Laboratory & Research
India's Dr Lal Pathlabs falls on volume growth concerns
India's Vijaya Diagnostic set for worst day in over 7 wks on Q3 profit fall
India's Dr. Lal PathLabs slides on fall in Q3 earnings
Kotak Institutional flags margin concerns at Dr. Lal PathLabs
India's diagnostic, pharma stocks up as fears of COVID resurgence mount
India's Dr. Lal PathLabs slumps over 5% on Q2 profit fall
India's Dr. Lal PathLabs Q2 profit slumps on falling COVID income, higher expenses
Brief: India's Dr. Lal Pathlabs Sept-Quarter Consol Net Profit Falls
India's Dr. Lal Pathlabs jumps most in over a month
India's Dr. Lal Pathlabs touches 5-month high
Brief: India's Dr. Lal Pathlabs June-Quarter Consol Net Profit Falls
Brief: Dr. Lal Pathlabs Ltd March-Quarter Consol Net Profit Down
Brief: Dr. Lal Pathlabs Approves Acquisition Of 100% Stake In Suburban Diagnostics (India)
Brief: India's Dr. Lal Pathlabs Sept-Quarter Consol Net Profit 950 Mln Rupees
Brief: India's Dr. Lal Pathlabs June Qtr Consol Net Profit Rises
Brief: Dr. Lal Pathlabs March Quarter Consol Net Profit Jumps
Brief: Dr. Lal Pathlabs Reports Higher Dec Qtr Profit
Brief: Dr. Lal Pathlabs - Unit To Buy Bindish Diagnostic Lab On Going Concern Basis